EMJ | Elevating the quality of healthcare globally

This site is intended for healthcare professionals

Continue

Latest News

All News
Phase 3 Trial Supports Vunakizumab for axSpA
Rheumatology
22 May 2026

Phase 3 Trial Supports Vunakizumab for axSpA

Patients receiving vunakizumab for radiographic axial spondyloarthritis demonstrated improved clinical responses through 32 weeks, a new trial has shown.
Interventional Cardiology
22 May 2026

EuroPCR 2026: TTVI Surpasses Surgery in Tricuspid Regurgitation

Transcatheter treatment for tricuspid regurgitation increased more than tenfold in Germany between 2018–2023 and was associated with lower in-hospital mortality than surgery, according to data presented at EuroPCR 2026.
General Healthcare
22 May 2026

79th World Health Assembly: Maternal Deaths Set to Miss 2030 Target

The global maternal mortality ratio is around seven times lower than the rate needed to reach the SDG target, EMJ heard at the 79th World Health Assembly.
Psoriasis Text Messaging Improves CVD Prevention - EMJ
Dermatology
22 May 2026

Text Messaging Boosts Cardiovascular Risk Prevention in Psoriasis

A 6-month text-messaging programme improved cardiovascular risk self-management in adults with psoriasis in a randomised trial.
Lorlatinib Activity in Neuroblastoma Patients - EMJ
Oncology
22 May 2026

Lorlatinib Shows Promise in ALK Driven Neuroblastoma

Lorlatinib achieved high response rates in patients with ALK driven neuroblastoma, though efficacy varied by molecular profile and resistance patterns emerged.
Cardiology
22 May 2026

GLP-1 Receptor Agonists Reduce Cardiac Dysfunction in Cancer

Over a 12-month follow-up period, GLP-1 receptor agonists were associated with a significantly reduced risk of CTRCD, as well as lower rates of all-cause mortality, hospital admission, atherosclerotic events, and thrombotic complications.
Football Heading Linked to Brain Biomarker Changes
Neurology
22 May 2026

Football Heading Linked to Brain Biomarker Changes

Researchers have found that amateur football heading increased blood biomarkers associated with neural injury after competitive matches.
Microbiology & Infectious Diseases
22 May 2026

HIV Progress Uneven Across Middle East and North Africa

HIV cases continue to rise across the Middle East and North Africa despite progress in prevention and treatment, with stigma and inequality limiting care access for LGBTQIA+ communities.
RAAS Inhibitors Lower Liver Cancer Risk in MASLD - EMJ
Hepatology
22 May 2026

RAAS Inhibitors in MASLD Linked to Lower Liver Cancer Risk

RAAS inhibitor use in MASLD is linked to lower hepatocellular carcinoma risk in a large Taiwan cohort. Find out more from the study findings.

Latest Articles

Interactive Content

Respiratory
19 May 2026

IL-33 Is Not Just IL-33: There Is More Than One Side to the COPD Story

COPD exacerbations place a considerable burden on patients and healthcare systems.1-3 Even with optimised maintenance therapy, many…
Hepatology
15 Apr 2026

MASH and The Race for Liver Antifibrotics

Metabolic dysfunction-associated steatohepatitis (MASH), along with other chronic liver diseases, leads to progressive fibrosis and…
Hematology
15 Apr 2026

Entering a New Era in Protection in Haemophilia A

Haemophilia A (HA), defined by factor VIII (FVIII) levels ≤40 IU/dL, is a chronic condition with consequences beyond bleeding…
Dermatology
10 Apr 2026

Managing an Itchy Rash in an Infant

This interactive case study was organised and funded by Viatris. A 4-month-old female infant presented with itching and red skin patches…
All Interactive Content

Latest Infographics

All Infographics
Microbiology & Infectious Diseases
30 Apr 2026

HIV at a Crossroads: Innovation and Inequity

This infographic presents the current landscape of HIV care at a crossroads, where rapid advances in long-acting prevention and treatment..
CAMCEVI® (leuprolide mesylate) 42 mg Injectable Emulsion: Ready-to-Use Innovation in Androgen Deprivation Therapy
Urology
23 Apr 2026

Ready-to-Use Innovation in Androgen Deprivation Therapy

Androgen deprivation therapy (ADT) is essential in advanced prostate cancer but often requires complex, multi-step preparations…
Oncology
17 Apr 2026

The Importance of BRAF Testing in NSCLC

BRAF mutations are rare, occurring in around 2-4% of patients with NSCLC. Around 50% of BRAF mutations are BRAFV60 mutations, which mostly…
Reproductive Health
10 Apr 2026

Individualising MHT and its Impact on Long-term Health

MHT is the most effective treatment for the management of oestrogen deficiency symptoms and has been shown to prevent bone loss and…

Latest Podcasts

All Podcasts
Hematology
19 May 2026

Hema Now: The Future of Haemostasis, Haemophilia, and Rare Bleeding Disorders

In this episode of Hema Now, Giancarlo Castaman explores the evolution of haemostasis and haemophilia care, reflecting on how advances in….
Allergy & Immunology
18 May 2026

Infant Nutrition and Lifelong Immunity

In this series, host Catherine Glass speaks with Meghan Azad about how early-life nutrition influences immune development from birth…..
Oncology
15 May 2026

Navigating comorbidities and polypharmacy in mHSPC

This video podcast covers the current treatment landscape for mHSPC and covers the burden of comorbidities and polypharmacy. Our experts…
Onc Now: Expanding Genomics in Cancer Care
Oncology
14 May 2026

Onc Now: Expanding Genomics in Cancer Care

In this episode of Onc Now, we examine how genomics is reshaping cancer care, from risk prediction to treatment decisions and NHS…

Latest Videos & Webinars

All Videos & Webinars
EMJ
Rheumatology
22 May 2026

IL-1 in Focus: An Expert Question and Answer Session

Sobi has launched a four-part podcast series featuring leading experts in rheumatology, exploring the role of IL-1 in…
Diabetes
29 Apr 2026

Holistic Care in the Diabetes Review: The Alphabet Strategy

Tune in to the latest EMJ Webinar, exploring holistic diabetes care through the practical and evidence-based Alphabet Strategy. Guest…
Urology
27 Apr 2026

EMJ's latest Urology Journal

Urology is moving fast. The clinicians driving that change don’t wait to catch up—they lead.Get the clinical intelligence required to…
We’ve noticed you’re accessing
from North/South America.